Merck KGaA, Darmstadt, Germany Awards €500,000 Research Grant to Professor Lauren Gardner for AI-Based Pandemic Prevention Solutions

Award is a research grant of 500.000 € for AI-based solutions to prevent future pandemics Merck KGaA, Darmstadt, Germany CEO Belén Garijo ...

July 11, 2024 | Thursday | News
Daiichi Sankyo Expands European Presence with New Oncology Affiliate in Greece

Daiichi Sankyo  announced that it has opened a new affiliate for its oncology business in Athens, Greece. The establishment highlights the company&r...

July 10, 2024 | Wednesday | News
HepaRegeniX Secures €15M Series C Funding to Advance Liver Regeneration Therapy HRX-215

Funds to support Phase Ib clinical trial of HRX-215 in the US and an international multicenter Phase IIa clinical trial in liver regeneration Elias Pa...

July 10, 2024 | Wednesday | News
Roche Receives CE Mark for Accu-Chek® SmartGuide CGM Solution, Empowering Diabetes Management in Europe

Roche  announced  that it has received the CE Mark for its Accu-Chek® SmartGuide continuous glucose monitoring (CGM) solution. This signifi...

July 09, 2024 | Tuesday | News
Myricx Bio Secures £90m Series A Funding Co-Led by Novo Holdings and Abingworth

£90m ($114m) series A co-led by new leading life science investors Novo Holdings and Abingworth Additional new investors British Patient Capital...

July 08, 2024 | Monday | News
Iktos Acquires Synsight, Gains Exclusive License to INSERM's AI-Driven Screening Technology

Synsight provides Iktos with an exclusive worldwide license to INSERM’s patented technology enabling high performance AI-driven in cellulo screen...

July 08, 2024 | Monday | News
CSL Behring Achieves European Milestone with First Real-World Treatments of Hemophilia B Using HEMGENIX® Gene Therapy

Global biotechnology leader CSL Behring  announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dez...

July 04, 2024 | Thursday | News
Vertex Pharmaceuticals' Vanza Triple Granted Priority Review by FDA with Target Action Date of January 2, 2025

Vanza triple granted priority review with Prescription Drug User Fee Act (PDUFA) target action date of January 2, 2025 – - EU Marketing Authorizat...

July 03, 2024 | Wednesday | News
Hofseth BioCare ASA Transfers Eosinophil-Targeting Drug Candidate MA-022a to Subsidiary HBC Immunology Inc

Hofseth BioCare ASA ("HBC" or the "Company"), a global leader in marine lipid and peptide research,  announces the decision to transfer its eosinoph...

July 02, 2024 | Tuesday | News
Valneva's Single-Dose Chikungunya Vaccine, IXCHIQ®, Receives European Commission Approval

  Valneva SE , a specialty vaccine company, today announced that the European Commission (EC) has granted marketing authorization in Europe for Val...

July 01, 2024 | Monday | News
Dawn Health Partners with Merck to Develop Digital Solution for Growth Hormone Disorders

Dawn Health, the digital health company pioneering patient-first innovation, has announced they are working with leading global pharmaceutical company, M...

July 01, 2024 | Monday | News
WHO Awards Prequalification to Roche's HPV Test for Broad Use, Enhancing Global Cervical Cancer Screening

The World Health Organization (WHO) has awarded Roche's human papillomavirus (HPV) test prequalification designations for use on the cobas 5800 System ...

June 27, 2024 | Thursday | News
Merck Celebrates 100th Anniversary in Spain

Merck, a leading science and technology company, is proud to announce the celebration of its 100th anniversary in Spain. Since opening our first commercial...

June 27, 2024 | Thursday | News
Regulatory Review Begins for Bavarian Nordic's Single-Dose Chikungunya Vaccine in EU and U.S.

Regulatory review of the single-dose CHIKV VLP vaccine candidate for immunization to prevent disease caused by chikungunya virus infection in individua...

June 26, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close